ID: ALA3318482

Max Phase: Preclinical

Molecular Formula: C19H13BrClNO2S

Molecular Weight: 434.74

Molecule Type: Small molecule

Representations

Canonical SMILES:  N#Cc1ccccc1SC1=C(O)CC(c2c(Cl)cccc2Br)CC1=O

Standard InChI:  InChI=1S/C19H13BrClNO2S/c20-13-5-3-6-14(21)18(13)12-8-15(23)19(16(24)9-12)25-17-7-2-1-4-11(17)10-22/h1-7,12,23H,8-9H2

Standard InChI Key:  GWYLMRVMCFHIIN-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 434.74

Molecular Weight (Monoisotopic): 432.9539

AlogP: 5.98

#Rotatable Bonds: 3

Polar Surface Area: 61.09

Molecular Species: ACID

HBA: 4

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 3

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 4.43

CX Basic pKa:

CX LogP: 5.07

CX LogD: 2.21

Aromatic Rings: 2

Heavy Atoms: 25

QED Weighted: 0.64

Np Likeness Score: -0.80

References

1. Dragovich PS, Fauber BP, Boggs J, Chen J, Corson LB, Ding CZ, Eigenbrot C, Ge H, Giannetti AM, Hunsaker T, Labadie S, Li C, Liu Y, Liu Y, Ma S, Malek S, Peterson D, Pitts KE, Purkey HE, Robarge K, Salphati L, Sideris S, Ultsch M, VanderPorten E, Wang J, Wei B, Xu Q, Yen I, Yue Q, Zhang H, Zhang X, Zhou A..  (2014)  Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase.,  24  (16): [PMID:25037916] [10.1016/j.bmcl.2014.06.076]

Source

Source(1):

• Scientific Literature